Stevens Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,208
Closed -$246K 1052
2016
Q4
$246K Buy
+10,208
New +$284K 0.01% 734
2016
Q1
Sell
-8,370
Closed -$250K 1058
2015
Q4
$250K Buy
+8,370
New +$282K 0.01% 740

Other funds holding PGEN

Stevens Capital Management's PGEN Position: Q1 2017 in Review

Stevens Capital Management sold out of Precigen (PGEN) in Q1 2017, closing a stake of 10,208 shares — an estimated $246K sold.

Stevens Capital Management first reported a position in PGEN in Q4 2015 and held it in 2 quarters. The position peaked at $250K in Q4 2015. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2017.

  • Stevens Capital Management reported no remaining Precigen position as of Q1 2017 after selling out during the quarter.
  • Stevens Capital Management sold 10,208 Precigen shares in Q1 2017, an estimated $246K.
  • Stevens Capital Management first reported a position in Precigen in Q4 2015 and held it in 2 quarters.
  • Stevens Capital Management's Precigen position peaked at $250K in Q4 2015.
  • 154 funds tracked by Wall St. Rank held Precigen as of Q1 2017.

Based on Stevens Capital Management's 13F filing for Q1 2017, filed 8 May 2017.